stars 1 stars 2 stars 3

SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.

SignPath Pharma Inc. Questions

The SignPath Pharma Inc. annual revenue was $23000 in 2026.

Kai Larson is the President and CEO of SignPath Pharma Inc..

5 people are employed at SignPath Pharma Inc..

SignPath Pharma Inc. is based in Sandy, Utah.

The NAICS codes for SignPath Pharma Inc. are [325, 3254, 32541, 32].

The SIC codes for SignPath Pharma Inc. are [283, 28].

Top SignPath Pharma Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users